Theravance Biopharma TBPH

$ 17.08 0.03%

Quarterly report 2026-Q2
added 08-11-2026

Theravance Biopharma DIO Ratio | TBPH

Annual DIO Ratio Theravance Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	1.02 K	1.54 K	784	1.13 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.54 K	784	1.12 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Qilian International Holding Group Limited QLI	145	-	-6.08 %	$ 184 M	China
	Happiness Biotech Group Limited HAPP	11.6	-	1.35 %	$ 17.8 M	China
	Завод ДИОД DIOD	768	-	-	-	Russia
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Codexis CDXS	70.7	$ 1.46	2.82 %	$ 127 M	USA
	Ardelyx ARDX	989	$ 3.78	1.89 %	$ 911 M	USA
	Affimed N.V. AFMD	69.8	-	-34.95 %	$ 21.5 M	Germany
	Arcutis Biotherapeutics ARQT	185	$ 23.9	1.01 %	$ 3.04 B	USA
	AnPac Bio-Medical Science Co., Ltd. ANPC	34.5	-	-1.58 %	$ 28.1 M	China
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Axsome Therapeutics AXSM	168	$ 206.68	0.16 %	$ 10.3 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BioMarin Pharmaceutical BMRN	644	$ 66.53	0.15 %	$ 12.8 B	USA
	BeiGene, Ltd. BGNE	334	-	0.49 %	$ 251 B	Cayman-islands
	ChromaDex Corporation CDXC	36.3	-	-0.88 %	$ 598 M	USA